IndraLab

Statements


1 | 2

reach
"Carboplatin treatment downregulates constitutive NF-kappaB activity and prevents nuclear retention of p65 in liver cancer [XREF_BIBR] and glioma cell lines [XREF_BIBR]."

No evidence text available

reach
"Carboplatin treatment downregulated constitutive NF-kappaB activity and prevented nuclear retention of p65."